Treatment Preferences Of Patients With Advanced Ovarian Cancer For The Addition Of Bevacizumab To First Line TherapyY. Park,J. Y. Lee,E. J. Nam,S. Kim,S. W. Kim,Y. T. KimINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2016）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
